MicroRNA‑127‑5p attenuates severe pneumonia via tumor necrosis factor receptor‑associated factor 1

  • Authors:
    • Cunrong Chen
    • Sen Lin
    • Lili Zhou
    • Jingjing Wang
    • Junnian Chen
    • Ranjie Yu
    • Haoteng Luo
    • Junli Lu
    • Zhiqiang Xue
    • Mingzhi Chen
  • View Affiliations

  • Published online on: July 13, 2020     https://doi.org/10.3892/etm.2020.8997
  • Pages: 2856-2862
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pneumonia is a persistent and pervasive disease, the effects of which can be severe. MicroRNA (miR)‑127‑5p has been utilized as a novel biomarker for the diagnosis of severe pneumonia. The present study aimed to investigate the function of miR‑127‑5p during severe pneumonia. An in vitro model of severe pneumonia in Ana‑1 murine macrophages was established using lipopolysaccharide (LPS). Subsequently, reverse transcription‑quantitative PCR and ELISA were performed to detect the mRNA and protein expression levels of interleukin (IL)‑1β, IL‑6 and tumor necrosis factor (TNF)‑α. Western blotting was also performed to measure the activity of AKT and NF‑κB. The results indicated that compared with the control group, LPS treatment increased TNF receptor‑associated factor 1 (TRAF1) expression levels and reduced miR‑127‑5p expression levels. Furthermore, the results revealed that the 3'‑untranslated region of TRAF1 was targeted by miR‑127‑5p. miR‑127‑5p mimic reduced LPS‑induced increases in IL‑1β, IL‑6 and TNF‑α expression by targeting TRAF1, which was potentially mediated by inactivation of the AKT and NF‑κB signaling pathways. Collectively, the results demonstrated that miR‑127‑5p may attenuate severe pneumonia by reducing LPS‑induced inflammatory cytokine production, and inactivating the AKT and NF‑κB signaling pathways by targeting TRAF1.

Related Articles

Journal Cover

September-2020
Volume 20 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen C, Lin S, Zhou L, Wang J, Chen J, Yu R, Luo H, Lu J, Xue Z, Chen M, Chen M, et al: MicroRNA‑127‑5p attenuates severe pneumonia via tumor necrosis factor receptor‑associated factor 1. Exp Ther Med 20: 2856-2862, 2020
APA
Chen, C., Lin, S., Zhou, L., Wang, J., Chen, J., Yu, R. ... Chen, M. (2020). MicroRNA‑127‑5p attenuates severe pneumonia via tumor necrosis factor receptor‑associated factor 1. Experimental and Therapeutic Medicine, 20, 2856-2862. https://doi.org/10.3892/etm.2020.8997
MLA
Chen, C., Lin, S., Zhou, L., Wang, J., Chen, J., Yu, R., Luo, H., Lu, J., Xue, Z., Chen, M."MicroRNA‑127‑5p attenuates severe pneumonia via tumor necrosis factor receptor‑associated factor 1". Experimental and Therapeutic Medicine 20.3 (2020): 2856-2862.
Chicago
Chen, C., Lin, S., Zhou, L., Wang, J., Chen, J., Yu, R., Luo, H., Lu, J., Xue, Z., Chen, M."MicroRNA‑127‑5p attenuates severe pneumonia via tumor necrosis factor receptor‑associated factor 1". Experimental and Therapeutic Medicine 20, no. 3 (2020): 2856-2862. https://doi.org/10.3892/etm.2020.8997